We are live on ! Find out more
NBTX

Nanobiotix

10 hedge funds and large institutions have $25.6M invested in Nanobiotix in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $20.6M → $25.6M (+$4.93M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.25% less ownership

Funds ownership: 12.22%11.98% (-0.25%)

17% less funds holding

Funds holding: 1210 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
2
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NBTX Hedge Fund Activity: Q2 2025 in Review

10 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q2 2025, worth a combined $25.6M — up 24% from $20.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NBTX and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, adding an estimated $5.49K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $376K sold.

  • 10 institutional investors held Nanobiotix (NBTX) as of Q2 2025, down from 12 in Q1 2025.
  • Funds reported $25.6M of Nanobiotix stock for Q2 2025, up 24% quarter-over-quarter.
  • 2 funds opened new Nanobiotix positions in Q2 2025 and 4 closed out, a net change of -2 holders.
  • The largest Nanobiotix buyer in Q2 2025 was UBS Group, an estimated $5.49K added.
  • The largest Nanobiotix seller in Q2 2025 was Perceptive Advisors, an estimated $376K sold.

Based on aggregated 13F filings for Q2 2025.